#148 CF Series: Shuling Guo on Pharmaceuticals

Get a shoutout on the podcast by nominating DNA Today for the Quill Podcast Awards for the “Best Health Podcast”. Share your nomination on social media and tag us. In return, we will thank you personally on the show, you can also comment on our posts on Twitter, Facebook, LinkedIn and Instagram. Nominate in this form! Sponsoring this series is Picture Genetics, a unique DNA testing service, with tests designed for every stage of life -- including family planning. With a Picture Parenting carrier test, you can uncover genetic conditions that may be passed on to your kids such as cystic fibrosis. Unlike other companies, this is a clinical grade test where physicians and genetic counselors are involved. It’s easy to order and understand with good looking reports! To order your Picture Genetics test, go to picturegenetics.com and use code “DNATODAY”for 25% off and free-shipping! Get actionable genetic insights today to benefit your family of tomorrow.To continue our cystic fibrosis podcast series, Dr. Shuling Guo joins our host Kira Dineen, to discuss drug discovery efforts in cystic fibrosis. She is the VP of Antisense Drug Discovery at Ionis Pharmaceuticals – the leader in RNA-targeted drug discovery and development. Shuling is an Ionis veteran of over a dozen years (first and only industry job). Shuling received her Ph.D. in Molecular Cancer Biology from Duke University and had her postdoctoral training at HHMI/UCLA. At Ionis, Dr. Guo oversees drug discovery efforts in hematological, metabolic, ocular, pulmonary and renal disease areas as well as research efforts in noncoding RNA field; managing activities from target identification and target validation to the selection of human development candidate. In addition, she is involved in clinical development of antisense therapies. Her achievements include leading the research efforts for transthyretin (familial amyloid polyneuropathy, completed phase 3 clinical trial & under NDA), TMPRSS6 (beta-thalassemia and hereditary hemochromatosis, phase 1 clinical trial), and ENaC (cystic fibrosis, preclinical development). Want to become a genetic counselor? Looking for ways to engage with the field and boost your resume for grad school applications? Then you should check out Sarah Lawrence’s “Why Genetic Counseling Wednesday Summer Series”! Every Wednesday this June Sarah Lawrence is hosting this series where you can interact through Zoom with genetic counselors from different specialties for an hour and a half. It kicks off on June 2nd! Register today on Sarah Lawrence’s website to level up your resume for applications in the fall. On This Episode We Discuss:Defining cystic fibrosis (CF)How CFTR protein functions in the lung, difference in lung of CF patientsCurrent drugs on the market for CFResearch and development on a drug through Ionis Antisense medicine and how it works in the body Other respiratory diseases that could benefit from this treatment The timeline for FDA-approval and commercial availability of this drugFor more information about Ionis’ new cystic fibrosis drug development (IONIS-ENAC-2.5Rx), check out their press release here. You can learn more about Ionis on their website and follow Dr. Shuling Guo on LinkedIn. Don’t forget to enter our cystic fibrosis giveaway of the book, “Breath From Salt”. The author, Bijal P. Trivedi, was on our first episode of the cystic fibrosis podcast series. Head over to our Twitter, Instagram, LinkedIn, and Facebook to enter to win a free copy!Stay tuned for the next new episode of DNA Today on June 4th, 2021! We will be joined by Gunnar Esiason, patient advocate, for the third and final episode of our CF series! New episodes are released on the first and third Friday of the month. In the meantime, you can binge over 150 other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Brand new in 2021, episodes are now also recorded with video which you can watch on